20/05/2026
π Key Facts About Tirzepatide
- Dual action mechanism: Activates both GLP-1 and GIP receptors, boosting insulin release and reducing glucagon levels.
- Blood sugar control: Improves glycemic control in type 2 diabetes patients.
- Weight loss benefits: Suppresses appetite and slows gastric emptying, leading to significant weight reduction in clinical trials.
- Dosage: Starts at 2.5 mg weekly, gradually increased up to 15 mg depending on patient response.
- Administration: Subcutaneous injection once a week, can be taken with or without food.
- Common side effects: Nausea, diarrhea, and digestive discomfort.
- Precautions: Not suitable for patients with type 1 diabetes, history of pancreatitis, or certain thyroid cancers.